Test. Treat. Hepatitis
Viral hepatitis B and C are major health challenges, affecting 325 million people globally. They are root causes of liver cancer, leading to 1.34 million deaths every year.
Hepatitis B and C are chronic infections that may not show symptoms for a long period, sometimes years or decades. At least 60% of liver cancer cases are due to late testing and treatment of viral hepatitis B and C. Low coverage of testing and treatment is the most important gap to be addressed in order to achieve the global elimination goals by 2030.
WHO will focus on the theme: "Test. Treat. Hepatitis" for World Hepatitis Day 2018 events. WHO events and activities can aim to achieve the following objectives globally, in regions and in countries:
To support scale-up of hepatitis prevention, testing, treatment and care services, with specific focus on promoting WHO testing and treatment recommendations;
To showcase best practices and promote universal health coverage of hepatitis services; and
To improve partnerships and funding in the fight against viral hepatitis
WHO and the Government of Mongolia will hold a series of events in Ulaanbaatar, Mongolia to commemorate the World Hepatitis Day 2018. The events will engage high-level leaders, advocates and patient representatives from global, regional and national organizations, highlighting the innovative solutions and partnerships needed in scaling up hepatitis testing and treatment services, as well as celebrating the country's championing experience in the global hepatitis response.
Timely testing and treatment of viral hepatitis B and C can save lives.
Stories from around the world
Europe: Universal access to testing and treatment is key to eliminating viral hepatitis
10 things to know about viral hepatitis
Useful documents
